secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-07-14T23:59:59+00:00
Accession:  0001607062-21-000214
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma begins audit of FY2020 financials to cure reporting delinquency
-------------------------------------------------------------------------------

- BF Borgers CPA PC started audit of FY2020 financial statements on July 8, 2021.
- Audit is a step towards filing overdue Form 10-K for fiscal year ended September 30, 2020.
- Borgers also audited FY2019 and FY2018 statements for the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000214/0001607062-21-000214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000214/rgbp071321form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer